Related Experiment Video
Updated: May 12, 2026
10:35
Multimodal Imaging and Spectroscopy Fiber-bundle Microendoscopy Platform for Non-invasive, In Vivo Tissue Analysis
Published on: October 17, 2016
The diagnostic evaluation of MelaFind multi-spectral objective computer vision system.
Erine A Kupetsky1, Laura K Ferris
1University of Pittsburgh School of Medicine, Department of Dermatology, Pittsburgh, PA 15213, USA.
Expert Opinion on Medical Diagnostics
|April 2, 2013
Summary
The MelaFind device aids physicians in early melanoma detection, potentially reducing melanoma morbidity and mortality. Its high sensitivity and objective output can improve biopsy decisions, though cost may limit widespread adoption.
Area of Science:
- Dermatology
- Medical Devices
- Computer Vision
Background:
- Melanoma incidence is rising, with over 75,000 US diagnoses in 2012.
- Early detection is crucial for reducing melanoma morbidity and mortality.
- Current physician screenings rely on unaided visual inspection.
Purpose of the Study:
- To review the MelaFind device for melanoma detection.
- To evaluate its sensitivity, specificity, limitations, and clinical role.
- To discuss other emerging melanoma detection technologies.
Main Methods:
- Literature review of MelaFind and other melanoma detection devices.
- Analysis of sensitivity, specificity, and clinical utility.
- Assessment of MelaFind's role in assisting biopsy decisions.
Main Results:
- MelaFind is an FDA-approved multispectral computer vision system.
- It offers high sensitivity and acceptable specificity for melanoma detection.
- Objective output aids clinicians in biopsy decisions.
Conclusions:
- MelaFind may improve early melanoma detection and reduce mortality.
- Its ease of use and objective data assist both experienced and less experienced clinicians.
- Cost and lack of insurance reimbursement may hinder widespread use.
